All In Biotech

Free tool

FAERS Monitor: Lescol Xl

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021192 or its brand name (Lescol Xl, Fluvastatin Sodium). Reports on generic versions are filed under their own applications.

Reports

4,471

Serious

3,641

81% of reports

Hospitalization

1,949

Death reported

462

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea319
  • myalgia317
  • dizziness298
  • fatigue280
  • diarrhoea255
  • drug ineffective253
  • dyspnoea250
  • asthenia243
  • myocardial infarction221
  • fall211
  • vomiting207
  • arthralgia201
  • headache195
  • cerebrovascular accident180
  • pyrexia180

Reports by year received

View as table
YearReports
2004359
2005422
2006355
2007238
2008232
2009257
2010259
2011351
2012254
2013165
2014179
2015192
2016182
2017145
2018167
2019126
2020117
2021132
2022108
202364
202493
202540
202634

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,688 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
myalgiaSignal3178.87.92,193
myocardial infarctionSignal2216.05.2915
cerebrovascular accidentSignal1805.04.3576
astheniaSignal2433.02.7337
fallSignal2113.02.6281
dizzinessSignal2982.82.5354
pyrexiaSignal1802.42.1155
arthralgiaSignal2012.32.0145
dyspnoeaSignal2502.11.8143
vomitingSignal2072.11.8116
nausea3191.91.7139
diarrhoea2551.91.6103
fatigue2801.71.582
headache1951.51.329
drug ineffective2530.90.83

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.